Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity

Neurofilament light chain (NfL) has been demonstrated to correlate with multiple sclerosis disease severity as well as treatment response. Nevertheless, additional serum biomarkers are still needed to better differentiate disease activity from disease progression. The aim of our study was to assess...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Sci Rep
Huvudupphovsmän: Ayrignac, Xavier, Le Bars, Emmanuelle, Duflos, Claire, Hirtz, Christophe, Maleska Maceski, Aleksandra, Carra-Dallière, Clarisse, Charif, Mahmoud, Pinna, Frédéric, Prin, Pauline, Menjot de Champfleur, Nicolas, Deverdun, Jérémy, Kober, Tobias, Marechal, Bénédicte, Fartaria, Mario Joao, Corredor Jerez, Ricardo, Labauge, Pierre, Lehmann, Sylvain
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group UK 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7331703/
https://ncbi.nlm.nih.gov/pubmed/32616916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-67934-2
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk